Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04623138 · ClinicalTrials.gov registry record
A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections
A clinical trial, sponsored by Evidation Health.
- Completed
- Registry status
- 847
- Enrollment target
NCT04623138: Completed study, sponsored by Evidation Health.
NCT04623138 is a clinical trial that has completed, run by Evidation Health. The registered enrollment target is 847 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04623138 has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- 847 participants
- Enrollment target
Study Summary
Prospective, observational, exploratory study exploring the relationship between passively-collected data from wearable activity devices and SARS-CoV-2 infection
Primary Outcome
To develop a database of physiological and behavioral data via wearable devices and self-reported questionnaires (e.g.,symptoms) combined with laboratory confirmation of SARS- CoV-2 infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 847 participants |
| Start Date | 2020-11-04 |
| Est. Completion | 2021-06-01 |
What the finished NCT04623138 record still lists
NCT04623138 is an observational study that tracks outcomes without assigning an intervention. The registered 847 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04623138 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04623138 about?
NCT04623138 is a clinical study titled "A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections". Prospective, observational, exploratory study exploring the relationship between passively-collected data from wearable activity devices and SARS-CoV-2 infection
What is the current status of trial NCT04623138?
This trial is currently completed. The enrollment target is 847 participants. The study started on 2020-11-04. Estimated completion is 2021-06-01.
Who is sponsoring clinical trial NCT04623138?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07142408 · 848 participants · Phase 3
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
- NCT02757859 · 845 participants · NA
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI